Use of radical cystectomy for patients with invasive bladder cancer.
about
Treatment of bladder cancer in the elderlyProtein Profiling of Bladder Urothelial Cell CarcinomaHow to optimally manage elderly bladder cancer patients?Investigation of poorer bladder cancer survival in women in NSW, Australia: a data linkage study.Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base.Association of hospital volume with conditional 90-day mortality after cystectomy: an analysis of the National Cancer Data Base.Laparoscopic versus open radical cystectomy in bladder cancer: a systematic review and meta-analysis of comparative studiesIdentification of underserved areas for urologic cancer care.Compliance with guidelines for patients with bladder cancer: variation in the delivery of care.Care transitions between hospitals are associated with treatment delay for patients with muscle invasive bladder cancer.Bias in estimating the causal hazard ratio when using two-stage instrumental variable methods.Hospital-level variation in the quality of urologic cancer surgery.Methods in comparative effectiveness research.Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research.Urothelial carcinoma management in elderly or unfit patients.Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis.Patterns of care in patients with muscle-invasive bladder cancer - a retrospective cohort study.Laparoscopic Radical Cystectomy in the Elderly - Results of a Single Center LRC only Series.Optimizing care and outcomes of patients with muscle-invasive bladder cancer.Survival impact of followup care after radical cystectomy for bladder cancer.Urinary diversion practice patterns among certifying American urologistsNeoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer.Does patient age affect survival after radical cystectomy?Improving bladder cancer patient care: a pharmacoeconomic perspective.Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit.Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma.Contemporary evidence for robot-assisted radical cystectomy for treating bladder cancer.The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.The Relationship between Centralization of Care and Geographic Barriers to Cystectomy for Bladder Cancer.Robot-assisted partial cystectomy: perioperative outcomes and early oncological efficacy.Treatment Effect Estimation Using Nonlinear Two-Stage Instrumental Variable Estimators: Another Cautionary Note.Population-based assessment of racial/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer.Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: sub-analysis of the multi-institutional national database of the Japanese Urological Association.Detection of Intratumor Heterogeneity in Modern Pathology: A Multisite Tumor Sampling Perspective.Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: Yes.Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy.Development and validation of a reference table for prediction of postoperative mortality rate in patients treated with radical cystectomy: a population-based study.Editorial comment from Dr Smith to Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy.Radical cystectomy in the elderly - Is this a safe treatment option?Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology.
P2860
Q26744163-54C55193-8F97-4AF2-BC25-90112F69788CQ27324419-2DA465B6-840B-4299-9073-0DD6AC580319Q28076939-3DA42653-0ECB-480D-9DE4-2B6D096A9F4CQ30677893-7CA8DA9D-DC84-4711-AB10-E5FC53897A63Q30712462-8D880EB9-3C64-4A79-B29A-FD6D45BC40C9Q33605299-C772FED3-4498-46B0-BF04-AE1E2842AE80Q33623496-398456C1-801B-4E98-A199-116A3FEC09CAQ34541452-B540E1DD-0278-4FD5-8013-6AB6C2B32344Q35501135-5DE95A66-B5A4-4CCC-9E74-24CE51A425BAQ35576964-2A241B63-7E69-4D17-B736-ABF627C82A27Q35684054-6ECABB75-09F7-46F7-91BF-275EBC733CAFQ35740209-E30DF12C-E869-4516-A209-00E7D702A225Q36417734-73323EF9-B0B2-4256-BE07-DF021C2D4308Q36959541-F80E3E5C-6FF4-403D-A241-E3569492436BQ37030514-95DD6B57-98F2-4754-A377-B69C1F6C2A4FQ37077160-8B089D2E-8E15-4968-843E-82D7396FFEA8Q37274375-5AF80F3D-FF21-44FF-A201-CF8558D8CD79Q37426968-307F2952-B36A-4398-AD8F-ECEDB4742D0DQ37455252-73B29527-AE5C-42F2-80FE-877324279FB1Q37495636-C50A5591-4463-4096-B294-2C1B7606C1A4Q37567621-9E79F1D5-9598-4DAB-A52B-50B510DCE5F2Q37735161-B3781EA5-8414-48BB-BE6D-432AFE14D1D3Q38007021-2A125167-A5C1-417F-A121-F1AF2E77C69DQ38114945-5112B8B7-49EE-462D-8BB6-563342D13119Q38615547-47370BF6-3E57-4252-AE9D-F24BB290CE82Q38621223-7BAD210F-D460-4B76-89C4-2D18C4B2DD7DQ38833271-23CA6FEE-F866-4ECA-BBE6-0424056A3690Q39480721-600576AE-B4AA-415F-BAEB-1040E5F88A00Q39513953-8138CC49-D63F-4581-A283-7CF881309C3AQ39748435-95C24F93-F6B5-44CB-BF5D-C998549A094BQ39986513-2331C70B-5EFF-404C-9AD2-4AA585658030Q40212938-5E5F77BC-1FC6-44BE-9FBF-E7F34AE6BCA0Q40925557-58655A31-6464-4B28-9D39-7CEC5F7760BAQ42256371-E60AF095-D8E1-4B6B-A680-70B23EE04CDDQ42350221-F23D0E8C-AD22-47A8-9921-5DA1579B5CF1Q43742712-3E39BDAB-863D-46F6-836F-8AD5AAFEC654Q44276267-C14969C7-40E6-4AEE-94CD-B01D0E2E4C94Q44741716-809C5D6C-6BC8-4937-A955-BDD8F053E251Q47109760-D44F84A6-1318-44F4-82A1-0ED586AA6190Q47992784-D99CA90C-E85D-4808-8151-592BB4583706
P2860
Use of radical cystectomy for patients with invasive bladder cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Use of radical cystectomy for patients with invasive bladder cancer.
@ast
Use of radical cystectomy for patients with invasive bladder cancer.
@en
type
label
Use of radical cystectomy for patients with invasive bladder cancer.
@ast
Use of radical cystectomy for patients with invasive bladder cancer.
@en
prefLabel
Use of radical cystectomy for patients with invasive bladder cancer.
@ast
Use of radical cystectomy for patients with invasive bladder cancer.
@en
P2093
P2860
P356
P1476
Use of radical cystectomy for patients with invasive bladder cancer
@en
P2093
Christopher S Saigal
Claude Setodji
Elizabeth M Yano
John L Adams
Mark S Litwin
Rodger Madison
Urologic Diseases in America Project
P2860
P304
P356
10.1093/JNCI/DJQ121
P407
P50
P577
2010-04-16T00:00:00Z